Search

everythinglearnresearchcommunity

for

Search:↓

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Progerin affects cell shape but not hair or skin in mice.

Studying premature aging syndromes helps understand human aging and suggests potential treatments.

Light affects skin health, aging, and cancer risk, and new light-based treatments and imaging are promising for skin care.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.

Choosing the right estroprogestin is crucial for effectively managing PCOS symptoms.

Extracellular vesicles can both worsen and help treat age-related diseases and are useful for early diagnosis.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Treat significant hirsutism with medication and hair removal; use birth control pills first, adding antiandrogens if needed.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Dermatologists recommend oral dutasteride for male hair loss, low-dose oral minoxidil for female hair loss, and a multidisciplinary approach for young patients, with caution during pregnancy.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Including androgens in hormone therapy may lower breast cancer risk.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Platelet-Rich Plasma therapy helps increase hair density and regrowth for some types of hair loss.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Finasteride with oral contraceptive helps improve hair loss in premenopausal women.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.